Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
e-cigarette e-liquid-University of Southern California refers to a range of experimental e-cigarette liquid formulations used as research materials in clinical laboratory studies conducted by the University of Southern California, such as the study titled 'Effects of e-Cigarettes on Perceptions and Behavior - Substudy 1' (NCT04399031). These formulations are not commercial pharmaceutical products but are designed to evaluate how specific product characteristics—including flavor profiles (tobacco, menthol, fruit, dessert) and nicotine formulations—impact product appeal, nicotine delivery kinetics, and abuse liability in young adult vapers and adult smokers. The primary active pharmacological ingredient is nicotine, which acts as an agonist at nicotinic acetylcholine receptors (nAChRs) in the central nervous system. By stimulating these receptors, nicotine facilitates the release of neurotransmitters like dopamine, mediating reinforcing effects. These e-liquids are administered via aerosol inhalation using electronic nicotine delivery systems (ENDS) to provide data that can inform potential tobacco product regulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on e-cigarette e-liquid-University of Southern California.